Literature DB >> 27118192

Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications.

Laura Salanova Villanueva1, Carmen Sánchez González2, José Antonio Sánchez Tomero2, Abelardo Aguilera2, Esther Ortega Junco2.   

Abstract

Cardiovascular factors are one of the main causes of morbidity and mortality in patients with chronic kidney disease. Bone mineral metabolism disorders and inflammation are pathological conditions that involve increased cardiovascular risk in chronic kidney disease. The cardiovascular risk involvement of bone mineral metabolism classical biochemical parameters such as phosphorus, calcium, vitamin D and PTH is well known. The newest markers, FGF23 and klotho, could also be implicated in cardiovascular disease.
Copyright © 2016 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; Chronic kidney disease; Enfermedad renal crónica; FGF23; Klotho; Riesgo cardiovascular

Mesh：

Substances：

Year:  2016        PMID： 27118192     DOI： 10.1016/j.nefro.2016.01.011

Source DB:  PubMed          Journal:  Nefrologia        ISSN： 0211-6995            Impact factor:   2.033


  6 in total

Review 1.  Potential application of klotho in human chronic kidney disease.

Authors:  Javier A Neyra; Ming Chang Hu
Journal:  Bone       Date:  2017-01-20       Impact factor: 4.398

Review 2.  Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health.

Authors:  Federica Bellone; Maria Cinquegrani; Ramona Nicotera; Nazareno Carullo; Alessandro Casarella; Pierangela Presta; Michele Andreucci; Giovanni Squadrito; Giuseppe Mandraffino; Marcello Prunestì; Cristina Vocca; Giovambattista De Sarro; Davide Bolignano; Giuseppe Coppolino
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

Review 3.  Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins.

Authors:  Marta Latko; Aleksandra Czyrek; Natalia Porębska; Marika Kucińska; Jacek Otlewski; Małgorzata Zakrzewska; Łukasz Opaliński
Journal:  Cells       Date:  2019-05-14       Impact factor: 6.600

4.  Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.

Authors:  Hong Jae Yi; Jong Bok Lee; Kyu Pil Lee; Ye-In Oh; Kun Ho Song; Kyoung Won Seo
Journal:  BMC Vet Res       Date:  2020-07-16       Impact factor: 2.741

Review 5.  The role of klotho in chronic kidney disease.

Authors:  Di Zou; Wen Wu; Yan He; Sichao Ma; Ji Gao
Journal:  BMC Nephrol       Date:  2018-10-22       Impact factor: 2.388

6.  The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio, Deemed the Nephron Index, Is a Useful Clinical Index for Early Stage Chronic Kidney Disease in Patients with Type 2 Diabetes: An Observational Pilot Study.

Authors:  Hodaka Yamada; Makoto Kuro-O; Shunsuke Funazaki; San-E Ishikawa; Masafumi Kakei; Kazuo Hara
Journal:  Int J Nephrol       Date:  2018-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.